TECH
NASDAQ · Life Sciences Tools & Services
Bio-Techne Corp
$72.78
+0.12 (+0.17%)
Financial Highlights (FY 2026)
Revenue
1.21B
Net Income
181.62M
Gross Margin
66.2%
Profit Margin
15.0%
Rev Growth
+2.3%
D/E Ratio
0.09
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 66.2% | 66.2% | 39.4% | 39.4% |
| Operating Margin | 20.7% | 18.7% | 9.4% | 9.0% |
| Profit Margin | 15.0% | 14.2% | 7.1% | 7.4% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 1.21B | 1.19B | 4.96B | 3.84B |
| Gross Profit | 803.76M | 786.07M | 1.95B | 1.51B |
| Operating Income | 251.54M | 221.40M | 467.28M | 345.45M |
| Net Income | 181.62M | 159.86M | 349.73M | 285.59M |
| Gross Margin | 66.2% | 66.2% | 39.4% | 39.4% |
| Operating Margin | 20.7% | 18.7% | 9.4% | 9.0% |
| Profit Margin | 15.0% | 14.2% | 7.1% | 7.4% |
| Rev Growth | +2.3% | +2.3% | -8.8% | +23.8% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 494.55M | 494.55M | 586.61M | 603.00M |
| Total Equity | 5.21B | 5.21B | 6.41B | 5.49B |
| D/E Ratio | 0.09 | 0.09 | 0.09 | 0.11 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 274.91M | 255.42M | 713.51M | 532.70M |
| Free Cash Flow | — | — | 309.30M | 255.34M |